Please login to the form below

Not currently logged in
Email:
Password:

Clinigen acquires Idis for £225m

Acquisition makes them the global leader in unlicensed medicines

edit-clinigen-big 

Clinigen Group is to acquire unlicensed medicines supplier Idis for £225m.

The ethical unlicensed supply market is estimated to be worth in excess of $5bn and upon completion, Clinigen claims it will become the market leader. 

Peter George, CEO of Clinigen, commented: “This acquisition satisfies a number of our key strategic goals – achieving market leader position in the $5+billion unlicensed medicine supply sector and strengthening our leading position in the $2 billion clinical trial supply market.

“The acquisition will also accelerate our growth and give us a much better balanced portfolio of businesses, whilst extending our unique business model.”

Idis supplies unlicensed medicines predominantly on an exclusive basis through managed access programmes as well as on demand via its general access division.

George concluded: “The enlarged entity creates an incredibly exciting business with tremendous opportunities for growth. I am confident that, together with Idis, we have the right people to define and shape the unlicensed medicine supply market - an increasingly important health care sector for patients with unmet needs.”

Article by
Kirstie Pickering

27th April 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...